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Abstract 
By imaging neuronal excitation in rat spinal cord slices with a voltage-sensitive dye, we 
examined the role of glial cells in the P2X receptor agonist, αβ-methylene ATP, 
(αβmeATP)-triggered long-term potentiation (LTP) in the dorsal horn. Bath application of 
αβmeATP potentiated neuronal excitation in the superficial dorsal horn. The potentiation 
was inhibited in the presence of P2X receptor antagonists, TNP-ATP, PPAADS and 
A-317491, and was not induced in slices taken from rats neonatally treated with capsaicin. 
These results suggest that αβmeATP acts on P2X receptors, possibly P2X3 and/or P2X2/3 
in capsaicin-sensitive primary afferent terminals. Furthermore, the potentiation was 
inhibited by treatment with the glial metabolism inhibitor, monofluoro-acetic acid. Results 
obtained with the p38 mitogen-activated protein kinase (p38 MAPK) inhibitor, SB203580, 
tumor necrosis factor-α (TNF-α), interleukin (IL)-6, and antibodies to TNF-α and IL-6, 
as well as by double immunolabeling of activated p38 MAPK with markers of astrocytes 
and microglia, demonstrated that αβmeATP activated p38 MAPK in astrocytes, and that 
the presence of proinflammatory cytokines and p38 MAPK activation were necessary 
for the induction of αβmeATP-triggered LTP. These findings indicate that glial cells 
contribute to the αβmeATP-induced LTP, which might be part of a cellular mechanism 
for the induction of persistent pain. 
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Introduction 
Peripheral inflammation or tissue injury increases the sensitivity to noxious stimuli 
(hyperalgesia) and/or induces pain sensation by light-touch (allodynia). Long-term 
potentiation (LTP) of synaptic strength in the spinal dorsal horn is now believed to be a 
mechanism of such persistent pain (Sandkühler & Liu, 1998; Ma & Zhao, 2002; Ikeda et al., 
2003; Ikeda & Murase, 2004). Adenosine triphosphate (ATP) is a major sensory 
neurotransmitter that activates a family of P2X receptor-modulated cation channels in the 
peripheral and central nervous systems (Jahr & Jessell, 1983; Krishtal et al., 1983; Khakh et 
al., 2001). In hippocampal CA1 neurons, it is reported that LTP can be induced by 
extracellular application of ATP (Yamazaki et al., 2003), and a large number of behavioral 
studies have reported a contribution of spinal cord P2X receptors to hyperalgesia and 
allodynia (Tsuda et al., 1999; Barclay et al., 2002; McGaraughty et al., 2003; Chen et al., 
2005). However, it is not known whether ATP can induce LTP in the spinal dorsal horn.  
Glial cells, including microglia and astrocytes, in the spinal dorsal horn play a role in the 
induction and maintenance of pathological pain due to inflammation or nerve injury. The 
density of glial cells in the spinal cord increases after nerve injury (Garrison et al., 1994), 
and blocking the activation of spinal cord glial cells with fluorocitrate, an inhibitor of glial 
metabolic activity, prevents the induction of allodynia and hyperalgesia (Meller et al., 
1994; Milligan et al., 2003). It was recently suggested that glial cell-dependent mechanisms 
are necessary for induction of LTP. In spinal cord slices, we have reported that a glial 
metabolic inhibitor blocks LTP of optically recorded neuronal excitation induced by 
low-frequency conditioning stimulation to the dorsal root (Ikeda & Murase 2004). An in 
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vivo study showed that disrupting the function of glial cells by a glial metabolic inhibitor 
blocked tetanic sciatic stimulation-induced LTP of C-fiber-evoked field potentials in the 
spinal dorsal horn (Ma & Zhao, 2002). A large number of studies indicate the contribution 
of astrocytes to persistent pain (Coyle, 1998; Hashizume et al., 2000; DeLeo et al., 2000; 
Stuesse et al., 2001). Although evidence for glial contribution to the LTP in spinal dorsal 
horn has accumulated, the underlying mechanism is still unclear. 
In this study using optical imaging with a voltage-sensitive dye, we show that 
extracellular application of the P2X receptor agonist, αβmeATP, induces LTP of neuronal 
excitation in the spinal dorsal horn, and that glial cell-dependent mechanisms are involved 
in the LTP induction. 
 
Materials and Methods 
 
Preparation 
All animal studies were undertaken according to protocols approved by the university 
animal ethics committee. Briefly, 18- to 25-day-old Wister rats were anaesthetized by 
diethyl ether. After performing laminectomy, the spinal cord was excised and several 
transverse slices (500 μm thick) with dorsal root attached were prepared from the 
lumbosacral enlargement. The animals were then sacrificed by an over dose of ether. Each 
slice was stained in a bath filled with the voltage-sensitive absorption dye, RH-482 (0.1 
mg/ml, 20 min), and set in a submersion-type chamber (0.2 ml) on an inverted microscope 
(IMT, Olympus, Tokyo) equipped with a 150-W halogen lamp. Slices were perfused with 
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Ringer’s solution containing (in mM): 124 NaCl, 5 KCl, 1.2 KH2PO4, 1.3 MgSO4, 2.4 
CaCl2, 26 NaHCO3, 0.2 thiourea, 0.2 ascorbic acid, and 10 glucose (oxygenated with 95% 
O2 and 5% CO2) at room temperature (23 ± 2°C). 
 
Optical recording 
The light absorption change, at a wavelength of 700 ± 32 nm, in a 0.83 mm2 area of the 
dorsal horn was recorded by an imaging system (Deltalon 1700, Fuji Film Co., Tokyo) with 
128 × 128 pixel photo sensors at a frame rate of 0.6 ms. The image of the spinal cord slice 
was focused on the photo sensors by an objective lens (magnification ×10, numerical 
aperture 0.30, Olympus). The cut end of the dorsal root attached to the slice was drawn into 
a glass suction electrode filled with Ringer’s solution, and was stimulated by a current 
pulse of 2 mA and a duration of 0.5 ms. The electrode was made by hand-pulling a standard 
Pasteur pipette over flame, and the orifice was made just to fit the dorsal root. Two silver 
wires, one from the inside of the pipette and another from the orifice, were connected to the 
stimulator. Eight single pulses were given at a constant interval of 15 s. Starting 10 ms 
before each stimulus, the image sensor took 128 consecutive frames of the light-absorption 
images at a sampling interval of 0.6 ms. A reference frame taken immediately before each 
series of 128 frames was subtracted from the subsequent 128 frames. Eight series of 
difference images were averaged and stored in the system memory. The initial frame was 
determined by averaging the first 15 frames of the difference image and then subtracting 
this average from each of the 128 frames of the image data on a pixel-by-pixel basis to 
eliminate the effects of noise contained in the reference frame. The ratio image was then 
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calculated by dividing the image data by the reference frame. 
 
Neonatal capsaicin treatment 
Postnatal day 2 rats were anaesthetized with diethyl ether and injected subcutaneously at 
the dorsal cervix with a capsaicin solution (50 mg/kg). Three weeks after the injection, rats 
were tested for one min on a hot plate (65°C). While normal, untreated rats raised and 
licked their feet within 10 s, successfully treated rats did not react for at least one min. 
 
Immunohistochemistry 
Slices (500 μm) incubated in αβmeATP for 0, 10, 20, and 50 min were fixed in ice-cold 4% 
paraformaldehyde and sunk in 30% sucrose for 48 h at 4°C. The slices were then sectioned 
(30 μm), blocked in 3% normal goat serum (NGS), and incubated for 48 h at 4°C in 
anti-phospho-p38 MAPK (1:200; Cell Signaling, Beverly, MA). In addition, antibodies 
directed against markers of microglia, OX42 (anti-OX42, 1:1000, Serotec, Oxford, UK) 
and astrocytes, glial fibrillary acidic protein (GFAP; anti-GFAP, 1:500; 
Boehringer-Mannheim, Indianapolis, IN) were used to identify the type of phospho-p38 
MAPK-positive cells. Following incubation, tissue sections were washed and incubated for 
3 h at room temperature in the secondary antibody solution (anti-rabbit IgG-conjugated 
Alexa FluorTM 488 or anti-mouse IgG-conjugated Alexa Fluor 546, 1:1,000; Molecular 
Probes, Eugene, OR). The spinal cord sections were analyzed using an Axiovert 200M 
microscope equipped with a Zeiss LSM 510 confocal laser-scanning microscope (Carl 
Zeiss, Jena, Germany). 
 6
 
Drugs 
The RH-482 (NK-3630) dye was obtained from Nippon Kanko Shikiso (Okayama, Japan). 
The D-2-amino-5-phosphonovaleric acid, αβ-methylene ATP, TNF-α, PPADS, A-317491, 
capsaicin, IL-6, monofluoroacetic acid, and SB203580 were from Sigma (St. Louis, MO). 
TNF-α and IL-6 antibodies and their control immunoglobulin G (IgG) were from R & 
D systems (Minneapolis, MN). 
 
Statistics 
Results were expressed as means ± SE. The Student’s paired t-test was used to exhibit 
statistical differences. 
 
Results 
 
αβmeATP-induced LTP of neuronal excitation evoked by C afferents 
 
We visualized gross neuronal excitation in the dorsal horn region of transverse spinal cord 
slices stained with the voltage-sensitive dye, RH-482 (Ikeda et al., 1998, 2004). A test 
stimulus, a single pulse of C fiber-activating strength to the dorsal root, evoked an optical 
response in spinal lamina I-III (Fig. 1A), representing the excitation of neurons throughout 
the thickness of the slice. 
First we examined the effect of the P2X receptor agonist αβmeATP on gross 
neuronal excitation in the spinal dorsal horn. Bath application of αβmeATP (100 μM) for 
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50 min significantly potentiated neuronal excitation in the superficial dorsal horn elicited 
by a test stimulus to the dorsal root (Fig. 1A,B,C). The magnitude of the neuronal 
excitation gradually increased and reached 141 ± 6 % (n = 5, p < 0.01) of control 350 
minutes after the application of αβmeATP (Fig. 1D). 
We then examined which of the seven P2X receptor subunits that comprise 
ATP-activated ion channels, contributes to αβmeATP-induced long-term potentiation (LTP) 
of neuronal excitation. As shown in Fig. 2, TNP-ATP (1 μM), a specific P2X1,2,3,4 
antagonist, PPAADS (20 μM), a specific P2X1,2,3,5 antagonist, and A-317491 (1 μM), a 
recently described selective P2X3 and P2X2/3 receptor antagonist, all blocked the induction 
of LTP by αβmeATP (TNP-ATP, 111 ± 4 %, p = 0.3, n = 5: PPADS, 109 ± 1 %, p = 0.3, n = 
4: A-317491, 108 ± 6 %, p = 0.9, n = 5). Application of antagonists alone did not affect the 
neuronal excitation evoked by dorsal root stimulation (TNP-ATP, 104 ± 4 %, p = 0.6, n = 5: 
PPADS, 103 ± 6 %, p = 0.7, n = 4). The αβmeATP-induced LTP is thus mediated primarily 
by the P2X3 and/or P2X2/3 receptors. 
The P2X3 receptor is selectively expressed in capsaicin-sensitive, small-diameter, 
primary sensory neurons (Ueno et al., 1999; Petruska et al., 2000). To investigate whether 
αβmeATP-induced LTP is dependent on C-fiber activity, we depleted most C fiber inputs 
by neonatal capsaicin treatment (Yang et al., 2003) and examined the effect of αβmeATP 
on the optical response in slices taken from these capsaicin-treated rats. In capsaicin-treated 
rats, neuronal excitation evoked in the dorsal horn by high-intensity stimulation (current 
pulse of 2 mA and a duration of 0.5 ms) was weaker than that in normal rats (Fig. 3A,B,C). 
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To confirm that capsaicin-sensitive C-fibers were abolished in capsaicin-treated rats, we 
examined the effect of capsaicin on neuronal excitation. In slices taken from normal rats, 
bath application of 1 μM capsaicin for 10 min significantly depressed neuronal excitation in 
the dorsal horn (-11.8 ± 1.4%, n = 4), but had no effect in slices from capsaicin-treated rats 
(4.3 ± 5.8%, n = 4, p < 0.05 compared with normal rat) (Fig. 3D). These results indicate 
that capsaicin-treated rats lacked capsaicin-sensitive afferents (Kusudo et al. 2006). The 
application of αβmeATP did not potentiate neuronal excitation in slices taken from the 
capsaicin-treated rats (Fig. 3E, 103 ± 4 %, p = 0.5, n = 4). 
 
Glial contribution to αβmeATP-induced LTP 
Recently, glial cells were proposed to be a key player in the induction of LTP in the central 
nervous system including the spinal dorsal horn (Ma & Zhao, 2002; Ikeda & Murase, 2004; 
Stellwagen & Malenka, 2006). Therefore, we next focused on the contribution of glial cells 
to αβmeATP-induced LTP of neuronal excitation. Treatment with the glial metabolism 
inhibitor, monofluoro-acetic acid 5 mM, starting 30 min before and continuing throughout 
the experiment, inhibited αβmeATP-induced LTP (Fig. 4, 108 ± 4 %, p = 0.3, n = 6). 
Monofluoro-acetic acid alone had no effect on neuronal excitation (Ikeda & Murase, 2004). 
Activation of glial cells is thus necessary for αβmeATP-induced LTP. 
To reveal how glial cells potentiate neuronal excitation, we examined the 
contribution of proinflammatory cytokines TNF-α and IL-6, which are transmitters released 
from glial cells and have been implicated in the induction and maintenance of pathological 
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pain (DeLeo et al., 1996;Hashizume et al., 2000;Sweitzer et al., 2001;Raghavendra et al., 
2003;Milligan et al., 2001, 2003;Raghavendra et al., 2002). The αβmeATP-induced LTP 
was blocked in slices that were pre-incubated in an antibody to rat TNF-α (anti-TNF-α, 10 
μg/ml) for one hour (Fig. 5A, 105 ± 2 %, p = 0.4, n = 4). Pre-incubation in the control 
IgG (10 μg/ml) for one hour, in contrast, did not affect the LTP induction by 
αβmeATP (Fig. 5A, 136 ± 6 %, p = 0.9, n = 4, compared to αβmeATP alone). 
Application of TNF-α (4 ng/ml) for 50 minutes potentiated neuronal excitation in the dorsal 
horn (Fig. 5B, 130 ± 8 %, p < 0.05, n = 4). However, in slices that were pre-incubated in 
αβmeATP for 50 min 3 hours before recording, TNF-α did not potentiate the neuronal 
excitation (Fig. 5B, 102 ± 4 %, p = 0.6, n = 4).  
In slices that were pre-incubated in an antibody to rat IL-6 (anti-IL6, 5 μg/ml) for 
one hour, αβmeATP-induced LTP was significantly less, especially at the late phase (Fig. 
5C, 118 ± 6 %, p = 0.2, and 113 ± 3 %, p < 0.01, at 120 and 270 min after αβmeATP 
application, respectively, n = 5, compared to αβmeATP alone). Pre-incubation in the 
control IgG (5 μg/ml) for one hour did not affect the induction of LTP (Fig. 5C, 134 ± 
6 %, p = 0.9, n = 4, compared to αβmeATP alone). The application of 40 nM IL–6 
potentiated neuronal excitation in slices that were pre-incubated in TNF-α for 50 minutes 3 
hours before recording (Fig. 5D, 128 ± 5 %, p < 0.05, n = 4), but did not potentiate 
neuronal excitation in slices not pre-incubated with TNF-α (Fig. 5D, 97 ± 6 %, p = 0.3, n = 
4). From these results, it is reasonable to conclude that TNF-α and IL-6 contribute to 
αβmeATP-induced LTP, and that pre-activation of the TNF-α receptor is necessary for the 
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potentiation of neuronal excitation by IL-6.  
p38 MAPK plays an important role in the induction of proinflammatory cytokines 
(Hua et al., 2002;Inoue et al., 2003;Chaparro-Huerta et al., 2005). We therefore examined 
the contribution of p38 MAPK to αβmeATP-induced LTP. In the presence of 1μM 
SB203580, a specific inhibitor of p38 MAPK, neuronal excitation was not potentiated by 
αβmeATP (Fig. 6A, 101 ± 6 %, p = 0.8, n = 4). To confirm that the glial cells expressed 
activated p38 MAPK, we performed double immunolabeling for activated p38 MAPK with 
anti-phospho extracellular signal-regulated kinase (anti-phospho-ERK) and for either 
astrocytes with GFAP or microglia with anti-OX42. In the first series of experiments, 
single immunofluorescence labeling in spinal cord slices showed that activation of p38 
MAPK is induced by αβmeATP. Phospho-ERK was strongly expressed in spinal cord slices 
incubated in αβmeATP for 10 and 20 min but not in those without αβmeATP treatment (Fig. 
6B-E). We also found that cells showing phospho-ERK immunofluorescence were double 
labeled for GFAP, but not for OX42, indicating that activated p38 MAPK was expressed in 
astrocytes but not in microglia (Fig. 6F,G). 
 
Mechanism of p38 MAPK activation in astrocytes 
We then examined how p38 MAPK is activated in astrocytes. It is known that MAPKs can 
be activated via Ca2+-permeable ionotropic receptors such as the N-methyl-D-aspartate 
(NMDA) receptor (Xia et al., 1996; Kawasaki et al., 1997). Therefore, we examined 
whether NMDA receptors contribute to αβmeATP-induced LTP of the neuronal excitation. 
In the presence of an NMDA receptor antagonist, D(–)-2-amino-5-phosphonopentanoic acid 
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(D-AP5, 50 μM), the potentiation of neuronal excitation by αβmeATP was inhibited (Fig. 
7A, 102 ± 9 %, p = 0.4, n = 5). We also examined whether it is possible to activate p38 
MAPK by directly activating NMDA receptors with NMDA. Although in neurons it is 
blocked by Mg2+, in glial cells activation of NMDA receptors is not affected by Mg2+ (Ziak 
et al., 1998, Hu et al., 2004; Lalo et al., 2006). In a solution containing Mg2+, the 
application of NMDA (50 μM) for 1 min significantly potentiated neuronal excitation 
elicited by a test stimulus (Fig. 7B). The magnitude of neuronal excitation gradually 
increased and reached 154 ± 22 % (p < 0.05, n = 6) of control 120 minutes after the 
application of NMDA. This LTP was blocked in the presence of the p38 MAPK inhibitor, 
SB203580 (Fig. 7B, 96 ± 11 %, p = 0.8, n = 5). These results indicate that p38 MAPK is 
activated via the NMDA receptor in astrocytes. 
 
Relationship between LTP induced by αβmeATP and conditioning stimulation 
Our previous study showed that low-frequency conditioning stimulation (LFS, 2 Hz for 2 
minutes) to the dorsal root potentiated optically-recorded neuronal excitation in the spinal 
dorsal horn for more that 4 hours, and the potentiation depended on glial cell activity (Ikeda 
and Murase, 2004). Therefore, here we examined whether LTP of neuronal excitation 
induced by LFS and by αβmeATP share the same mechanisms. The application of 
αβmeATP did not induce further potentiation in slices after pre induction of LTP by LFS, 
strongly suggesting that the two are related (Fig. 8, 134 ± 11 % 150 minutes after LFS, 130 
± 3 % 150 minutes after αβmeATP application, p = 0.8, n = 3). 
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Discussion  
 
In this study, we used spinal cord slices and optical imaging with a voltage-sensitive dye to 
record neuronal excitation in the spinal dorsal horn evoked by dorsal root stimulation. 
Neuronal excitation in the superficial dorsal horn was facilitated for more than 5 hours by 
αβmeATP. We investigated on, (1) the type(s) of receptors responsible for this potentiation, 
(2) the contributions of glial cells and cytokines to it, (3) its relation to the NMDA receptor, 
and finally (4) its relation to LTP induced by low frequency conditioning stimulation.  
 
αβmeATP-induced LTP and pain-related LTP in the dorsal horn 
In the present study, αβmeATP potentiated dorsal root-evoked neuronal excitation in the 
spinal dorsal horn. Electrophysiological studies report that LTP in the spinal dorsal horn is 
induced by repetitive high- and low-frequency conditioning stimulation to primary afferents 
and also by administration of natural inflammation mediators (Sandkühler & Liu, 1998; Ma 
& Zhao, 2002; Ikeda et al., 2003; Ikeda & Murase, 2004). It is known that ATP is released 
not only from primary afferent terminals (Jahr & Jessell, 1983; Krishtal et al., 1983; Khakh 
et al., 2001), but also from interneurons (Jo & Schlichter, 1999) and glial cells (Anderson et 
al., 2004). In addition, ATP is known as a mediator of pain (Tsuda et al., 1999; Barclay et 
al., 2002; McGaraughty et al., 2003; Chen et al., 2005). To our knowledge, this study is the 
first to demonstrate that activation of ATP receptors induces prolonged facilitation of 
evoked neuronal excitation in the superficial dorsal horn. That αβmeATP did not induce 
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facilitation once LTP was induced by low-frequency conditioning stimulation suggests that 
it might share some mechanisms with LFS-induced LTP, although additional 
pharmacological studies are necessary to clarify this relationship. It would also be 
interesting to know the source(s) of endogenous ATP as well as its actions in situ.  
 
Type and location of purinergic receptors activated by αβmeATP 
It is known that P2X receptors are expressed on neurons (Jo & Schlichter, 1999), glial cells 
(Anderson et al., 2004) and primary afferent terminals in the spinal dorsal horn (Cook et al., 
1997; Vulchanova et al., 1997, 1998; Llewellyn-Smith & Burnstock, 1998, Nakatsuka et al., 
2003). We here showed that LTP was induced by αβmeATP, a specific agonist for P2X1, 
P2X2, P2X2/3 and P2X3 receptors, and that it was inhibited by P2X1,2,3,4, P2X1,2,3,5, and 
selective P2X3/P2X2/3 receptor antagonists, (i.e., TNP-ATP, PPAADS, and A-317491, 
respectively). Therefore, αβmeATP-induced LTP of evoked neuronal excitation observed 
in the present study is likely to be mediated by P2X2/3 and/or P2X3 receptors.  
αβmeATP did not induce facilitation in slices taken from neonatal 
capsaicin-treated rats that lack the capsaicin-sensitive, small-diameter, primary afferent 
sensory neurons. The absence of αβmeATP-induced LTP in these slices might also be due 
to postsynaptic changes associated with the loss of fine afferent terminals. It is reported that 
P2X3 receptors are expressed in these neurons (Ueno et al., 1999; Petruska et al., 2000) and 
localized in primary afferent terminals in the dorsal horn (Cook et al., 1997; Vulchanova et 
al., 1997; 1998; Llewellyn-Smith & Burnstock, 1998). It is also suggested that P2X2/3 
receptors exist in capsaicin-insensitive dorsal root ganglion (DRG) neurons, but not in 
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capsaicin sensitive ones (Tsuda et al. 2000). It is therefore possible that αβmeATP-induced 
LTP might be mediated by P2X3 receptors in capsaicin-sensitive primary afferent terminals. 
However, at present there is no direct evidence for the presence of P2X2/3 receptors on the 
capsaicin-insensitive primary afferent terminals in the dorsal horn. Thus, further 
investigations are necessary to determine the exact site of αβmeATP action. 
 
Contribution of cytokines and astrocyte to αβmeATP-induced LTP 
The αβmeATP-induced LTP of neuronal excitation was inhibited by the metabolic inhibitor, 
monofluoro-acetic acid, which inhibits an enzyme found in the Krebs cycle of glia but not 
of neurons (Paulsen et al., 1987; Hassel et al., 1992). Furthermore, αβmeATP-activated p38 
MAPK was expressed in astrocytes. These results suggest the contribution of astrocytes to 
αβmeATP-induced LTP.  
αβmeATP-induced LTP was blocked by pre-application of an antibody to TNF-α, 
and the late phase of the potentiation was inhibited by pre-application of an antibody to 
IL-6. TNF-α alone also potentiated the neuronal excitation, a phenomenon that was 
inhibited by pre-administration of αβmeATP. IL-6 potentiated the neuronal excitation in 
slices pretreated with TNF-α, but not in untreated ones. It is reported that the expression of 
IL-6 receptors is increased by TNF-α (Inoue et al., 2003). This evidence is in agreement 
with, and provides an explanation for our data. That is, αβmeATP-induced LTP is mediated 
by the release of TNF-α and IL-6, and the release of TNF-α also increases the expression 
of IL-6 receptors that further enhances the potentiation of neuronal excitation. At present, 
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however, it is unclear whether or not other proinflammatory cytokines also contribute to 
αβmeATP-induced LTP. Further investigations are necessary to reveal the actions of 
cytokines on neurons and/or glial cells, especially those that directly record glial activities.  
In this study, αβmeATP-induced LTP was inhibited in the presence of the p38 
MAPK inhibitor SB203580, and double immunofluorescence labeling showed that 
αβmeATP-activated p38 MAPK was expressed in astrocytes, but not in microglia. These 
results indicate that activation of p38 MAPK is necessary for the induction of 
αβmeATP-induced LTP. There are a large number of reports that show proinflammatory 
cytokines are produced by intracellular signaling cascades triggered by p38 MAPK in glial 
cells (Hua et al., 2002; Inoue et al., 2003; Chaparro-Huerta et al., 2005). Therefore, it is 
possible that the proinflammatory cytokines that induced LTP in the present study are 
produced by the activation of p38 MAPK. To clarify the situation, more direct evidence is 
necessary concerning the activation of p38 MAPK by proinflammatory cytokines. 
 
Contribution of glial NMDA receptors to αβmeATP-induced LTP 
αβmeATP-induced LTP of neuronal excitation was inhibited in the presence of the 
NMDA-receptor antagonist D-AP5, and a similar LTP was induced by the application of 
NMDA. Reports show that NMDA receptors on dorsal horn neurons are involved in LTP 
induction (Ikeda et al., 2003; Ma & Zhao, 2002). Although glial cells also express NMDA 
receptors (Xia et al., 1996; Kawasaki et al., 1997), the contribution of glial NMDA 
receptors to LTP has not been reported. Our results indicated that αβmeATP-induced LTP is 
likely induced via NMDA receptors on astrocytes, because NMDA-induced LTP was 
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blocked by the inhibition of P38 MAPK activation in astrocytes following αβmeATP 
application. We have not completely ruled out the possible contribution of 
NMDA-receptors on neurons. 
Studies using whole-cell patch-clamp recordings showed that NMDA-evoked 
inward currents in glial cells are not sensitive to Mg2+, in contrast to those in neurons (Ziak 
et al., 1998, Hu et al., 2004; Lalo et al., 2006). In the present study, the application of 
NMDA in a solution containing Mg2+ facilitated neuronal excitation, further strengthening 
our hypothesis that αβmeATP-induced LTP is likely mediated by NMDA receptors on 
astrocytes. Because exact membrane potential values were not measured by our optical 
method, however, it is uncertain whether αβmeATP depolarized the membrane potential 
enough to remove the Mg2+ block from NMDA-receptor channels. In order to clarify this, it 
is necessary to measure the glial membrane potential with patch-clamp recording during the 
application of NMDA in a solution containing Mg2+. 
In conclusion, we demonstrated that in spinal dorsal horn slices from normal rats, 
extracellular application of αβmeATP triggered LTP of neuronal excitation via P2X 
receptors, possibly P2X3 and/or P2X2/3 in capsaicin-sensitive primary afferent 
terminals, in a TNFα- and IL-6-dependent manner. The αβmeATP-induced LTP was 
NMDA-dependent, and associated with p38 MAPK activation in astrocytes. The 
inhibition of p38 MAPK activation, and also the inhibition of glial metabolism, 
blocked the LTP induction. These results indicate the contribution of glial cells to the 
αβmeATP-induced LTP. After the LTP induced by low-frequency conditioning 
stimulation to the afferent fibers, αβmeATP was ineffective, the result suggesting that 
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both LTPs might share the same mechanism at least in part. The possible mechanism of 
LTP induction by αβmeATP is summarized in Fig. 9. To reveal the role of such LTP in pain 
sensation, experiments in vivo are surely necessary. 
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Figure Legends 
 
Fig. 1 
LTP of the neuronal excitation in the spinal dorsal horn by αβmeATP. A, Optical responses 
elicited by a single-pulse test stimulation to the dorsal root immediately before (left images) 
and 300 min after (right images) αβmeATP application. Images were taken from the area 
indicated by the black rectangle frame in the schematic drawing of a transverse slice in C. 
The times after the test stimuli are indicated to the left of the images. The percent change in 
light absorption is depicted using simulated color as described in the color bar. B, 
Superimposed time courses of optical responses in the pixels before (solid lines) and after 
(dashed lines) αβmeATP application. The time points are indicated by numbers 1 and 2 
in D. The traces are the responses of 3×2 pixels (at a 5-pixel interval on the image sensor) 
within the red rectangle on the schematic drawing in C. The stimulus pulses were given at 
the time indicated by the filled triangle. C, Schematic drawing of a transverse spinal cord 
slice (left), and the spatial averages of time courses before (solid line) and after (dashed 
line) αβmeATP application (right). Each time course was an average of 16 optical 
responses recorded by 4×4 pixels on the image sensor in the dorsal horn indicated by the 
black rectangle in the schematic drawing. We here call it the spatial average. D, The 
mean magnitudes of the optical responses with αβmeATP application (filled circles) and 
without (open circles). Magnitude of each response was obtained by the temporal 
average during 4.8 ms period after the onset of response which is indicated by vertical 
lines in C. Since the value is the temporal average of spatially-averaged time course, 
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we here call it the spatiotemporal average. The value was then normalized to the base 
line values before the application of αβmeATP. The mean magnitudes, as well as the 
standard errors, of the normalized spatiotemporal average values obtained in five 
slices with and without αβmeATP application were illustrated in the graph. The 
horizontal bar indicates the time when αβmeATP was applied. Graphs in the following 
figures represent such mean magnitudes and standard errors as well. 
 
Fig. 2 
Effect of various P2X receptor antagonists on the αβmeATP-induced LTP. LTP of neuronal 
excitation in the spinal dorsal horn, induced by αβmeATP, was inhibited in the presence of 
a specific P2X1,2,3,4 receptor antagonist, TNP-ATP (A), a specific P2X1,2,3,5 receptor 
antagonist, PPADS (B), and a specific P2X3 and P2X2/3 receptor antagonist, A-317491 (C). 
The optical responses were taken at every 8 min in 4-5 slices. The horizontal bars indicate 
the time when drugs were applied. 
 
Fig. 3 
The effect of αβmeATP on neuronal excitation in slices taken from capsaicin-treated rats. A, 
B, An example of optical responses elicited by single-pulse test stimulations to the dorsal 
root in a slice taken from a normal rat (A) and a capsaicin-treated rat (B). C, Spatial 
distributions of the optical responses shown in A (normal rat, black line) and B 
(capsaicin-treated rat, blue line) along a dorso-ventral line in the schematic drawing of 
transverse slices in A and B. The depth of the white matter and the substantia gelatinosa 
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are indicated by WM and SG, respectively. D, An example of superimposed time courses of 
optical responses in a slice taken from a normal rat (upper traces) and from a 
capsaicin-treated rat (lower traces) before capsaicin application (black lines) and after (red 
lines). E, The upper panel indicates superimposed time courses of optical responses in a 
slice taken from a capsaicin-treated rat before αβmeATP application (black line) and after 
(red line). The time points are indicated by numbers 1 and 2 in the lower panel. The 
lower panel indicates the mean magnitudes of the optical responses taken at every 8 min in 
four slices. The horizontal bar indicates the time when αβmeATP was applied. 
 
Fig. 4 
Contribution of glial cells to the αβmeATP-induced LTP. LTP of neuronal excitation in the 
spinal dorsal horn by αβmeATP was inhibited in the presence of the glial metabolism 
inhibitor, monofluoro-acetic acid (MFA). Upper panel indicates superimposed time 
courses of optical responses before (solid lines) and after (dashed lines) αβmeATP 
application. The time points are indicated by numbers 1 and 2 in the lower panel. The 
lower panel shows the mean magnitudes of optical responses obtained at every 8 min 
in six slices. The horizontal bar indicates the time when αβmeATP was applied. 
 
Fig. 5 
Contribution of TNF-α and IL-6 to αβmeATP-induced LTP in the spinal dorsal horn. A,  
αβmeATP-induced LTP was not observed in four slices that were pre-incubated with 
 30
antibody to rat TNF-α (filled circles), while it was present in four slices that were 
pre-incubated with the control IgG (open circles). The horizontal bar indicates the time 
when αβmeATP was applied. B, TNF-α facilitated neuronal excitation of the spinal dorsal 
horn in four control slices (filled circles), but not in four slices that were incubated in 
αβmeATP before recording (open circles). The horizontal bar indicates the time when 
TNF-α was applied. C, αβmeATP-induced LTP was significantly less in five slices that 
were incubated in antibody to rat IL-6 before recording (filled circles), while it was 
present in four slices that were pre-incubated with the control IgG (open circles). The 
horizontal bar indicates the time when αβmeATP was applied. D, IL-6 facilitated the 
neuronal excitation in four slices that were pre-incubated in TNF-α (open circles), but not 
in four slices without pre-application of TNF-α (filled circles). The horizontal bar indicates 
the time when IL-6 was applied. 
 
Fig. 6 
Contribution of p38 MAPK to the αβmeATP-induced LTP. A, αβmeATP-induced LTP was 
inhibited in the presence of a specific p38 MAPK inhibitor, SB203580, in four slices. The 
horizontal bar indicates the time when αβmeATP was applied. Upper panel indicates the 
superimposed time courses of optical responses before (solid lines) and after (dashed 
lines) αβmeATP application. The time points are indicated by numbers 1 and 2 in the 
lower panel. B-E, Immunofluorescence labeling with anti-phospho-p38 MAPK (green) in 
a spinal cord slice without αβmeATP incubation (B) and incubated in αβmeATP for 10 min 
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(C), 20 min (D), and 50 min (E). F, G, Double immunofluorescence labeling with 
anti-phospho-p38 MAPK (green) and with either anti-GFAP (F, red), a marker of 
astrocytes, or anti-OX42 (G, red), a marker of microglia. Most phospho-p38 
MAPK-positive cells are double labeled (yellow) with GFAP (F). 
 
Fig. 7 
Contribution of NMDA receptors to the αβmeATP-induced LTP. A, The LTP of neuronal 
excitation in the spinal dorsal horn induced by αβmeATP was inhibited in the presence of 
the NMDA receptor antagonist, D–AP5 in five slices. The horizontal bar indicates the time 
when αβmeATP was applied. B, Neuronal excitation was potentiated by a one min 
application of NMDA in six slices (filled circles) and the facilitation was not induced in the 
presence of the p38 MAPK inhibitor, SB203580, in five slices (open circles). Arrow 
indicates the time when NMDA was administered. 
 
Fig. 8 
Effect of αβmeATP given after low-frequency conditioning stimulation (LFS). αβmeATP 
that was applied after the induction of facilitation by LFS did not induce further facilitation 
of neuronal excitation in the spinal dorsal horn in three slices. Arrow indicates the time 
when LFS was applied. Horizontal bar indicates the time when αβmeATP was applied. 
 
Fig. 9 
Possible mechanism of LTP induction. Activation of presynaptic ATP receptors on fine 
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afferent fiber terminals, possibly of the P2X3 type, leads to facilitation of the afferent 
synaptic transmission. Cytokines TNF-α and IL-6 are necessary for the induction of 
facilitation. The sources and sites of action of these cytokines are yet to be identified. We 
propose that the activation of p38MAPK in astrocytes is initiated by the activation of 
NMDA receptors, which may release cytokines that facilitate the LTP. Low-frequency 
conditioning stimulation to afferent fibers may trigger the whole event by releasing 
glutamate and ATP.  
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